Skip to main content

Table 2 vaccines and corresponding antigenic proteins investigated in this study

From: In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect

Vaccine Protein Accession N° Reference
Tetanus Toxin protein AAA23282.1 [40]
Corynebacterium diphtheriae Toxin protein CAA00374.1 [40]
Hepatitis B HBsAg-adw2 AAW65557.1 [41]
HBsAg-adr AAW65588.1  
Bordetella pertussis Toxin protein AQW64178.1 [40]
Measles Hemagglutinin protein AAF85705.1  
Fusion protein AAF85704.1 [42]
Rubella Polyprotein E1/E2 ACN50046.1 [42]
Mumps Fusion protein ACN50030.1  
Hemagglutinin/neuraminidase protein ACN50032.1 [42]
Hepatitis A VP1 protein AAA45466.1  
VP3 protein AAA45466.1 [43, 44]
Bacillus Calmette-Guérin (BCG) Immunogenic protein MPB83 BAA11027.1  
Immunogenic protein MPB70 BAA07402.1 [45,46,47]
Immunogenic protein MPB64 AIC33023.1  
Hemophilus influenzae serotype B (Hib) Capsulation protein CWW30252.1 [40]
Capsular polysaccharide biosynthesis protein WP_015702013.1  
Poliovirus VP1 protein (Sabin 1 strain) AAL89597.1 [48]
VP1 protein (Sabin 2 strain) AAL92486.1  
VP1 protein (Sabin 3 strain) AAL89592.1  
Streptococcus pneumoniae (PCV10) Capsular polysaccharide biosynthesis protein [serotype 19F] AEO88919.1 [49]
Capsular polysaccharide biosynthesis protein [serotype 23F] AAC69522.1  
Capsular polysaccharide biosynthesis protein [serotype 18C] CAI33577.1  
Capsular polysaccharide biosynthesis protein [serotype 14] CAI33319.1  
Capsular polysaccharide biosynthesis protein [serotype 9 V] CAI33023.1  
Capsular polysaccharide biosynthesis protein [serotype 7F] CAI32924.1  
Capsular polysaccharide biosynthesis protein [serotype 6B] AAK20683.1  
Capsular polysaccharide biosynthesis protein [serotype 5] CAI32793.1  
Capsular polysaccharide biosynthesis protein [serotype 1] COS99248.1  
Capsular polysaccharide biosynthesis protein [serotype 4] AAK20668.1